Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis
Open Access
- 28 March 2022
- journal article
- research article
- Published by BMJ in Lupus Science & Medicine
- Vol. 9 (1) , e000599
Abstract
Objective Recent studies reported that SLE is characterised by altered interactions between the microbiome and immune system. We performed a meta-analysis of publications on this topic. Methods Case–control studies that compared patients with SLE and healthy controls (HCs) and determined the diversity of the gut microbiota and the abundance of different microbes were examined. Stata/MP V.16 was used for the meta-analysis. A Bonferroni correction for multiple tests was used to reduce the likelihood of false-positive results. Results We included 11 case–control studies that examined 373 patients with SLE and 1288 HCs. These studies were performed in five countries and nine cities. Compared with HCs, patients with SLE had gut microbiota with lower Shannon-Wiener diversity index (weighted mean difference=−0.22, 95% CI −0.32 to –0.13, p0.05). Patients with SLE who used high doses of glucocorticoids had altered gut microbiota based on the Chao1 species diversity estimator, and hydroxychloroquine use appeared to reduce the abundance of Enterobacteriaceae. Conclusions Patients with SLE have imbalanced gut microbiota, with a decrease in beneficial bacteria and an increase in harmful bacteria. Drugs used to treat SLE may also alter the gut microbiota of these patients.Keywords
Funding Information
- National Natural Science Foundation of China (81774179, 81973778)
This publication has 65 references indexed in Scilit:
- Human gut microbiome viewed across age and geographyNature, 2012
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2011
- Measures of adult systemic lupus erythematosus: Updated Version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM‐R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI‐2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI)Arthritis Care & Research, 2011
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and ImidazoquinolinesThe Journal of Immunology, 2011
- Has the Microbiota Played a Critical Role in the Evolution of the Adaptive Immune System?Science, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newbornsProceedings of the National Academy of Sciences of the United States of America, 2010
- Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell MonolayersThe Journal of Nutrition, 2009
- Multiplicity-Adjusted Sample Size RequirementsThe Journal of Clinical Psychiatry, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003